Resveratrol treatment has neuroprotective effects and prevents cognitive impairment after chronic cerebral hypoperfusion

References

• Farkas E, Luiten PG, Bari F. Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases. Brain Res Rev. 2007;54:162–80.
   PubMedGoogle Scholar
• Cechetti F, Worm PV, Pereira LO, Siqueira IR, Anetto C. The modified 2VO ischemia protocol causes cognitive impairment similar to that induced by the standard method, but with a better survival rate. Braz J Med Biol Res. 2010;43:1178–83.
   PubMed Web of Science ®Google Scholar
• Cechetti F, Pagnussat AS, Worm PV, Elsner VR, Ben J, da Costa MS, et al. Chronic brain hypoperfusion causes early glial activation and neuronal death, and subsequent long-term memory impairment. Brain Res Bull. 2012;87:109–16.
   PubMed Web of Science ®Google Scholar
• Chao XD, Fei F, Fei Z. The role of excitatory amino acid transporters in cerebral ischemia. Neurochem Res. 2010;35:1224–30.
   PubMed Web of Science ®Google Scholar
• Lau A, Tymianski M. Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch. 2010;460:525–42.
   PubMed Web of Science ®Google Scholar
• Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods. 1984;11:47–60.
   PubMed Web of Science ®Google Scholar
• Rypma B, D'Esposito M. Isolating the neural mechanisms of age-related changes in human working memory. Nat Neurosci. 2000;3:509–15.
   PubMed Web of Science ®Google Scholar
• Berry A, Bindocci E, Alleva E. NGF, brain and behavioral plasticity. Neural Plast. 2012;2012:784040.
   PubMed Web of Science ®Google Scholar
• Kidd PM. Integrated brain restoration after ischemic stroke – medical management, risk factors, nutrients, and other interventions for managing inflammation and enhancing brain plasticity. Altern Med Rev. 2009;14:14–35.
   PubMedGoogle Scholar
• Alleva E, Petruzzi S, Cirulli F, Aloe L. NGF regulatory role in stress and coping of rodents and humans. Pharmacol Biochem Behav. 1996;54:65–72.
   PubMed Web of Science ®Google Scholar
• Manni L, Rocco ML, Bianchi P, Soligo M, Guaragna M, Barbaro SP, et al. Nerve growth factor: basic studies and possible therapeutic applications. Growth Factors. 2013;31:115–22.
   PubMed Web of Science ®Google Scholar
• Chiaretti A, Falsini B, Aloe L, Pierri F, Fantacci C, Riccardi R. Neuroprotective role of nerve growth factor in hypoxicischemic injury. From brain to skin. Arch Ital Biol. 2011;149:275–82.
   PubMed Web of Science ®Google Scholar
• Zhang F, Liu J, Shi JS. Anti-inflammatory activities of resveratrol in the brain: role of resveratrol in microglial activation. Eur J Pharmacol. 2010;636:1–7.
   PubMed Web of Science ®Google Scholar
• Mokni M, Elkahoui S, Limam F, Amri M, Aouani E. Effect of resveratrol on antioxidant enzyme activities in the brain of healthy rat. Neurochem Res. 2007;32:981–7.
   PubMed Web of Science ®Google Scholar
• Simao F, Matte A, Pagnussat AS, Netto CA, Salbego CG. Resveratrol preconditioning modulates inflammatory response in the rat hippocampus following global cerebral ischemia. Neurochem Int. 2012;61:659–65.
   PubMed Web of Science ®Google Scholar
• Sinha K, Chaudhary G, Gupta YK. Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats. Life Sci. 2002;71:655–65.
   PubMed Web of Science ®Google Scholar
• Lu KT, Chiou RY, Chen LG, Chen MH, Tseng WT, Hsieh HT, et al. Neuroprotective effects of resveratrol on cerebral ischemia-induced neuron loss mediated by free radical scavenging and cerebral blood flow elevation. J Agric Food Chem. 2006;54:3126–31.
   PubMed Web of Science ®Google Scholar
• Gao D, Zhang X, Jiang X, Peng Y, Huang W, Cheng G, et al. Resveratrol reduces the elevated level of MMP-9 induced by cerebral ischemia-reperfusion in mice. Life Sci. 2006;78:2564–70.
   PubMed Web of Science ®Google Scholar
• Netto CA, Hodges H, Sinden JD, Le Peillet E, Kershaw T, Sowinski P, et al. Effects of fetal hippocampal field grafts on ischaemic-induced deficits in spatial navigation in the water maze. Neuroscience. 1993;54:69–92.
   PubMed Web of Science ®Google Scholar
• Canal Castro C, Pagnussat AS, Orlandi L, Worm P, Moura N, Etgen AM, et al. Coumestrol has neuroprotective effects before and after global cerebral ischemia in female rats. Brain Res. 2012;1474:82–90.
   PubMed Web of Science ®Google Scholar
• Pagnussat AS, Michaelsen SM, Achaval M, Ilha J, Hermel EE, Back FP, et al. Effect of skilled and unskilled training on nerve regeneration and functional recovery. Braz J Med Biol Res. 2012;45:753–62.
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265–75.
   PubMed Web of Science ®Google Scholar
• Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006;5:493–506.
   PubMed Web of Science ®Google Scholar
• Simao F, Matte A, Pagnussat AS, Netto CA, Salbego CG. Resveratrol prevents CA1 neurons against ischemic injury by parallel modulation of both GSK-3beta and CREB through P13-K/Akt pathways. Eur J Neurosci. 2012;36:2899–905.
   PubMed Web of Science ®Google Scholar
• Farkas E, Institoris A, Domoki F, Mihaly A, Luiten PG, Bari F. Diazoxide and dimethyl sulphoxide prevent cerebral hypoperfusion-related learning dysfunction and brain damage after carotid artery occlusion. Brain Res. 2004;1008:252–60.
   PubMed Web of Science ®Google Scholar
• Ohtaki H, Fujimoto T, Sato T, Kishimoto K, Fujimoto M, Moriya M, et al. Progressive expression of vascular endothelial growth factor (VEGF) and angiogenesis after chronic ischemic hypoperfusion in rat. Acta Neurochir Suppl. 2006;96:283–7.
   PubMedGoogle Scholar
• Farkas E, Donka G, de Vos RA, Mihaly A, Bari F, Luiten PG. Experimental cerebral hypoperfusion induces white matter injury and microglial activation in the rat brain. Acta Neuropathol. 2004;108:57–64.
   PubMed Web of Science ®Google Scholar
• Shin JA, Lee H, Lim YK, Koh Y, Choi JH, Park EM. Therapeutic effects of resveratrol during acute periods following experimental ischemic stroke. J Neuroimmunol. 2010;227:93–100.
   PubMed Web of Science ®Google Scholar
• Pagnussat AS, Simao F, Anastacio JR, Mestriner RG, Michaelsen SM, Castro CC, et al. Effects of skilled and unskilled training on functional recovery and brain plasticity after focal ischemia in adult rats. Brain Res. 2012;1486:53–61.
   PubMed Web of Science ®Google Scholar
• Yousuf S, Atif F, Ahmad M, Hoda N, Ishrat T, Khan B, et al. Resveratrol exerts its neuroprotective effect by modulating mitochondrial dysfunctions and associated cell death during cerebral ischemia. Brain Res. 2009;1250:242–53.
   PubMed Web of Science ®Google Scholar
• Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci. 2001;24:677–736.
   PubMed Web of Science ®Google Scholar
• Ohab JJ, Fleming S, Blesch A, Carmichael ST. A neurovascular niche for neurogenesis after stroke. J Neurosci. 2006;26:13007–16.
   PubMed Web of Science ®Google Scholar
• Zacchigna S, Ruiz de Almodovar C, Carmeliet P. Similarities between angiogenesis and neural development: what small animal models can tell us. Curr Top Dev Biol. 2008;80:1–55.
   PubMed Web of Science ®Google Scholar
• Moser KV, Reindl M, Blasig I, Humpel C. Brain capillary endothelial cells proliferate in response to NGF, express NGF receptors and secrete NGF after inflammation. Brain Res. 2004;1017:53–60.
   PubMed Web of Science ®Google Scholar
• Simao F, Pagnussat AS, Seo JH, Navaratna D, Leung W, Lok J, et al. Pro-angiogenic effects of resveratrol in brain endothelial cells: nitric oxide-mediated regulation of vascular endothelial growth factor and metalloproteinases. J Cereb Blood Flow Metab. 2012;32:884–95.
   PubMed Web of Science ®Google Scholar
• Nico B, Mangieri D, Benagiano V, Crivellato E, Ribatti D. Nerve growth factor as an angiogenic factor. Microvasc Res. 2008;75:135–41.
   PubMed Web of Science ®Google Scholar
• Lee TH, Kato H, Chen ST, Kogure K, Itoyama Y. Expression of nerve growth factor and trkA after transient focal cerebral ischemia in rats. Stroke. 1998;29:1687–96; discussion 1697.
   PubMed Web of Science ®Google Scholar
• Oderfeld-Nowak B, Bacia A. Expression of astroglial nerve growth factor in damaged brain. Acta Neurobiol Exp (Wars). 1994;54:73–80.
   PubMed Web of Science ®Google Scholar
• Schmidt-Kastner R, Aguirre-Chen C, Saul I, Yick L, Hamasaki D, Busto R, et al. Astrocytes react to oligemia in the forebrain induced by chronic bilateral common carotid artery occlusion in rats. Brain Res. 2005;1052:28–39.
   PubMed Web of Science ®Google Scholar
• Marosi M, Rakos G, Robotka H, Nemeth H, Sas K, Kis Z, et al. Hippocampal (CA1) activities in Wistar rats from different vendors. Fundamental differences in acute ischemia. J Neurosci Methods. 2006;156:231–5.
   PubMed Web of Science ®Google Scholar
• Font MA, Arboix A, Krupinski J. Angiogenesis, neurogenesis and neuroplasticity in ischemic stroke. Curr Cardiol Rev. 2010;6:238–44.
   PubMedGoogle Scholar